Press Releases Filter Filter Results Year 2024 (1) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) March 30, 2018 Abiomed to Appoint New Chief Financial Officer Todd A. Trapp March 5, 2018 Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations February 14, 2018 Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures February 13, 2018 Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery February 13, 2018 Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock February 1, 2018 Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year January 12, 2018 Abiomed Third Quarter Fiscal 2018 Earnings and Conference Call Notification January 8, 2018 Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year December 29, 2017 Abiomed to Present at the 36th Annual J.P. Morgan Healthcare Conference October 26, 2017 Abiomed Announces First Patient Treated with Impella® in Japan October 26, 2017 Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% October 19, 2017 Abiomed's Impella® Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations October 10, 2017 Abiomed Second Quarter Fiscal 2018 Earnings and Conference Call Notification September 20, 2017 Abiomed Receives FDA PMA Approval for Impella RP® for Right Heart Failure August 28, 2017 Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant … 9 10 11 12 …